Genes encoding the TH1 transcription factor T-bet and HLX-1, the TH1 effector cytokine IFN-γ and TH17 polarizing cytokines IL-23 and IL-1β, were expressed significantly lower in whole blood from IFN-β-treated than from untreated MS patients. This evidence concerns the gene TBX21 and myeloid sarcoma.